Drug intelligence / Profile preview

Orthonon

Development stage: Unknown
Lead developer: Ankh Pharmaceuticals
Administration: Oral, Topical

Overview

**Orthonon** is an Ankh Pharmaceuticals-branded Ayurvedic herbal product marketed in capsule and externally applied oil forms for arthritis-related conditions, including osteoarthritis, rheumatoid arthritis, spondylitis, and gout. The manufacturer characterizes it as an anti-arthritic product; however, its specific herbal ingredients, molecular targets, and evidence-based mechanism of action are not stated on the product page. ([ankhpharma.com](https://www.ankhpharma.com/orthonon.php))

Brand names: Orthonon

Beyond the preview

Go deeper on Orthonon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orthonon.

Explore the full profile